Alamar Biosciences, Inc. announced the death of board member Ian Ratcliffe, who served as an independent director since February 2024. Following this event, the Board decreased its authorized number of directors to five and appointed Nicholas Naclerio, Ph.D., to the Audit Committee. Alamar Biosciences, Inc. is a biotechnology company that develops proteomic-based diagnostic solutions.
